Amgen Stock (NASDAQ: AMGN) stock price, news, charts, stock research, profile.
Open | $265.720 |
Close | $269.980 |
Volume / Avg. | 2.437M / 2.928M |
Day Range | 265.720 - 271.680 |
52 Wk Range | 211.710 - 329.720 |
Market Cap | $144.982B |
P/E Ratio | 21.568 |
Dividend Yield | 3.340% |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 1.95% |
Days to Cover | 3.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Amgen (NASDAQ: AMGN) through any online brokerage.
Other companies in Amgen’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for Amgen (NASDAQ: AMGN) was reported by UBS on Wednesday, April 17, 2024. The analyst firm set a price target for 284.00 expecting AMGN to rise to within 12 months (a possible 5.07% upside). 44 analyst firms have reported ratings in the last year.
The stock price for Amgen (NASDAQ: AMGN) is $270.3 last updated April 26, 2024 at 4:03 PM EDT.
The next Amgen (AMGN) dividend date is projected to be Thursday, May 16, 2024.
Amgen’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Amgen.
Amgen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.